Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma (clinicaltrials.gov) - Oct 10, 2026 - P1 | N=18 | Recruiting | Sponsor: Nathan Denlinger | Initiation date: Sep 2026 ➔ Dec 2026 | Not yet recruiting ➔ Recruiting
Enrollment open • Trial initiation date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • CD19
|